SYNCHRONICITY PHARMA, INC.

Profile

Company Names

SYNCHRONICITY PHARMA, INC.
RESET THERAPEUTICS, INC.

Addresses

1416 SARATOGA AVENUE, #133, SAN JOSE, CA 95129

5205 PROSPECT ROAD, #133-135, SAN JOSE, CA 95129

5205 PROSPECT ROAD, #135-133, SAN JOSE, CA 95129

260 LITTLEFIELD AVENUE, SUITE 200, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(650) 235-4140
(650) 235-4150

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$62,676,720.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-01-11 
$1,600,000.00 
$3,000,000.00 
$1,400,000.00 
Debt 
5
2019-09-18 
$5,953,344.00 
$5,953,344.00 
$0.00 
Debt 
4
2018-06-13 
$1,500,000.00 
$1,500,000.00 
$0.00 
Debt 
3
2016-02-18 
$29,727,145.00 
$47,206,800.00 
$17,479,655.00 
Equity 
2
2014-06-30 
$9,100,000.00 
$12,000,000.00 
$2,900,000.00 
Debt 
1
2013-11-22 
$14,796,231.00 
$15,989,400.00 
$1,193,169.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GLENN 
 
BATCHELDER 
DIRECTOR, EXECUTIVE OFFICER
CIVITAS THERAPEUTICS, INC.   |  XYLOCOR THERAPEUTICS, INC.   |  SYNSPIRA, LLC   |  RESET THERAPEUTICS, INC.   |  KANTUM DIAGNOSTICS, INC.   |  SYNCHRONICITY PHARMA, INC.   |  KANTUM PHARMA, INC.
ROSS 
 
BERSOT 
EXECUTIVE OFFICER, DIRECTOR
RESET THERAPEUTICS, INC.
FREDERICK 
B 
CRAVES 
DIRECTOR
RESET THERAPEUTICS, INC.   |  SYNCHRONICITY PHARMA, INC.
HOYOUNG 
 
HUH 
DIRECTOR
CALIBRA MEDICAL, INC.   |  JENNEREX, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ANTRIABIO, INC.   |  RESET THERAPEUTICS, INC.   |  NUVESSE SKIN THERAPIES, INC.   |  JUUL LABS, INC.   |  REZOLUTE, INC.   |  EIDOS THERAPEUTICS, INC.   |  PLIANT THERAPEUTICS, INC.   |  AKARI THERAPEUTICS PLC
PAUL 
 
HUMPHRIES 
EXECUTIVE OFFICER
RESET THERAPEUTICS, INC.
BLAIR 
 
JACKSON 
DIRECTOR
CIVITAS THERAPEUTICS, INC.   |  RESET THERAPEUTICS, INC.   |  SYNCHRONICITY PHARMA, INC.
STEVE 
 
KAY 
DIRECTOR
RESET THERAPEUTICS, INC.   |  SYNCHRONICITY PHARMA, INC.
SHU 
 
KUROSAKI 
EXECUTIVE OFFICER
SYNCHRONICITY PHARMA, INC.
SHUICHI 
 
KUROSAKI 
EXECUTIVE OFFICER
RESET THERAPEUTICS, INC.   |  SYNCHRONICITY PHARMA, INC.
PETER 
 
SCHULTZ 
DIRECTOR
ARDELYX, INC.   |  RESET THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-01-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-01-11 
2019-10-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-09-18 
2018-06-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-06-13 
2016-02-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-18 
2015-10-07
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-30 
2015-06-01
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-30 
2015-01-08
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-30 
2014-07-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-30 
2013-12-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#